Physiological roles of neurite outgrowth inhibitors in myelinated axons of the central nervous system-implications for the therapeutic neutralization of neurite outgrowth inhibitors

Current Pharmaceutical Design

Volumn 13, Issue 24, 2007, Pages 2529-2537

  Ma, Quan Hong ^a   Yang, Wu Lin ^b   Nie, Du Yu ^a   Dawe, Gavin S ^c   Xiao, Zhi Cheng ^a,b  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Myelin associated glycoprotein; Myelinated axons; Oligodendrocyte precursor cells; Peripheral nervous system; TN R knockout mice

Indexed keywords

BETA1 INTEGRIN; COLLAGEN TYPE 6; CONTACTIN; EPIDERMAL GROWTH FACTOR; JAGGED1; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; NEUROCAN; NEUROGENIC DIFFERENTIATION FACTOR; NOGO 66 RECEPTOR; NOTCH1 RECEPTOR; PROTEIN NOGO A; PROTEOCHONDROITIN SULFATE; SODIUM CHANNEL; TENASCIN; VERSICAN; VOLTAGE GATED CALCIUM CHANNEL; VOLTAGE GATED SODIUM CHANNEL; NERVE GROWTH FACTOR;

CENTRAL NERVOUS SYSTEM DISEASE; HUMAN; MYELIN SHEATH; MYELINATED NERVE; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVE SPROUTING; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RANVIER NODE; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; SYNAPTOGENESIS; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; NERVE FIBER; PHYSIOLOGY;

ANIMALS; AXONS; HUMANS; MYELIN SHEATH; NERVE GROWTH FACTORS; RANVIER'S NODES;

EID: 34548431021     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161207781368602     Document Type: Review

References (86)

1. Ramon y Cajal S. In: Degeneration and regeneration of the nervous system. Oxford University Press, London. 1928.
2. Filbin MT. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci 2003; 4: 703-13.
3. Mandemakers WJ, Barres BA. Axon regeneration: It's getting crowded at the gates of TROY. Curr Biol 2005; 15: R302-R305.
4. Woolf CJ. No Nogo: Now where to go? Neuron 2003; 38: 153-6.
5. Raisman G. Myelin inhibitors: Does NO mean GO? Nat Rev Neurosci 2004; 5: 157-61.
6. Sandvig A, Berry M, Barrett LB, Butt A, Logan A. Myelin- reactive glia-, and scar-derived CNS axon growth inhibitors: Expression, receptor signaling, and correlation with axon regeneration. Glia 2004; 46: 225-51.
7. Benson MD, Romero MI, Lush ME, Lu QR, Henkemeyer M, Parada LF. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc Natl Acad Sci USA 2005; 102: 10694-9.
8. Goldberg JL, Vargas ME, Wang JT, Mandemakers W, Oster SF, Sretavan DW, et al. An oligodendrocyte lineage-specific semaphorin, Sema5A, inhibits axon growth by retinal ganglion cells. J Neurosci 2004; 24: 4989-99.
9. Berezovska O, McLean P, Knowles R, Frosh M, Lu FM, Lux SE, et al. Notch1 inhibits neurite outgrowth in postmitotic primary neurons. Neuroscience 1999; 93: 433-9.
10. Redmond L, Oh SR, Hicks C, Weinmaster G, Ghosh A. Nuclear Notch1 signaling and the regulation of dendritic development. Nat Neurosci 2000; 3: 30-40.
11. Wang S, Sdrulla AD, DiSibio G, Bush G, Nofziger D, Hicks C, et al. Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 1998; 21: 63-75.
12. Levy OA, Lab JJ, Levey AI. Notch signaling inhibits PC12 cell neurite outgrowth via RBP-J-dependent and -independent mechanisms. Dev Neurosci 2002; 24: 79-88.
13. Ang BT, Xu G, Xiao ZC. Therapeutic vaccination for central nervous system repair. Clin Exp Pharmacol Physiol 2006; 33: 541-5.
14. Buchli AD, Schwab ME. Inhibition of Nogo: A key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system. Ann Med 2005; 37: 556-67.
15. Liebscher T, Schnell L, Schnell D, Scholl J, Schneider R, Gullo M, et al. Nogo-A antibody improves regeneration and locomotion of spinal cord-injured rats. Ann Neurol 2005; 58: 706-19.
16. Xu G, Nie DY, Chen JT, Wang CY, Yu FG, Sun L, et al. Recombinant DNA vaccine encoding multiple domains related to inhibition of neurite outgrowth: A potential strategy for axonal regeneration. J Neurochem 2004; 91: 1018-23.
17. Salzer JL. Polarized domains of myelinated axons. Neuron 2003; 40: 297-318.
18. Bhat MA. Molecular organization of axo-glial junctions. Curr Opin Neurobiol 2003; 13: 552-559.
19. Baron M. An- overview of the Notch signalling pathway. Semin Cell Dev Biol 2003; 14: 113-9.
20. Bianchi S, Dotti MT, Federico A. Physiology and pathology of notch signalling system. J Cell Physiol 2006; 207: 300-8.
21. Louvi A, Rtavanis-Tsakonas S. Notch signalling in vertebrate neural development. Nat Rev Neurosci 2006; 7: 93-102.
22. Justice NJ, Jan YN. Variations on the Notch pathway in neural development. Curr Opin Neurobiol 2002; 12: 64-70.
23. Hu QD, Ang BT, Karsak M, Hu WP, Cui XY, Duka T, et al. F3/ contactin acts as a functional ligand for Notch during oligodendrocyte maturation. Cell 2003; 115: 163-75.
24. Cui XY, Hu QD, Tekaya M, Shimoda Y, Ang BT, Nie DY, et al. NB-3/ Notch1 pathway via Deltex1 promotes neural progenitor cell differentiation into oligodendrocytes. J Biol Chem 2004; 279: 25858-65.
25. Hu QD, Ma QH, Gennarini G, Xiao ZC. Cross-talk between F3/contactin and Notch at axoglial interface: A role in oligodendrocyte development. Dev Neurosci 2006; 28: 25-33.
26. Popko B. Notch signaling: A rheostat regulating oligodendrocyte differentiation? Dev Cell 2003; 5: 668-9.
27. Li M, Shibata A, Li C, Braun PE, McKerracher L, Roder J, et al. Myelin-associated glycoprotein inhibits neurite/axon growth and causes growth cone collapse. J Neurosci Res 1996; 46: 404-14.
28. McKerracher L, David S, Jackson DL, Kottis V, Dunn RJ, Braun PE. Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 1994; 13: 805-11.
29. Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, Filbin MT. A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 1994; 13: 757-767.
30. Johnson PW, Bramow-Newerly W, Seilheimer B, Sadoul R, Tropak MB, Arquint M, et al. Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function. Neuron 1989; 3: 377-85.
31. Turnley AM, Bartlett PF. MAG and MOG enhance neurite outgrowth of embryonic mouse spinal cord neurons. Neuroreport 1998; 9: 1987-90.
32. McGee AW, Strittmatter SM. The Nogo-66 receptor: Focusing myelin inhibition of axon regeneration. Trends Neurosci 2003; 26: 193-8.
33. Montag D, Giese KP, Bartsch U, Martini R, Lang Y, Bluthmann H, et al. Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. Neuron 1994; 13: 229-246.
34. Schachner M, Bartsch U. Multiple functions of the myelin-associated glycoprotein MAG (siglec-4a) in formation and maintenance of myelin. Glia 2000; 29: 154-65.
35. Poliak S, Peles E. The local differentiation of myelinated axons at nodes of Ranvier. Nat Rev Neurosci 2003; 4: 968-80.
36. Marcus J, Dupree JL, Ponko B. Myelin-associated glycoprotein and myelin galactolipids stabilize developiag axo-glial interactions. J Cell Biol 2002; 156: 567-77.
37. Nie DY, Zhou ZH, Ang BT, Teng FY, Xu G, Xiang T, et al. Nogo-A at CNS paranodes is a ligand of Caspr: Possible regulation of K(+) channel localization. EMBO J 2003; 22: 5666-78.
38. Wang X, Chun SJ, Treloar H, Vartanian T, Greer CA, Strittmatter SM. Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci 2002; 22: 5505-15.
39. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci 2004; 5: 146-56.
40. Schachner M, Taylor J, Bartsch U, Pesheva P. The perplexing multifunctionality of janusin, a tenascin-related molecule. Perspect Dev Neurobiol 1994; 2: 33-41.
41. Joester A, Faissner A. The structure and function of tenascins in the nervous system. Matrix Biol 2001; 20: 13-22.
42. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, et al. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 2002; 416: 636-40.
43. Moon LD, Asher RA, Rhodes KE, Fawcett JW. Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC. Nat Neurosci 2001; 4: 465-466.
44. Aspberg A, Binkert C, Ruoslahti E. The versican C-type lectin domain recognizes the adhesion protein tenascin-R. Proc Natl Acad Sci USA 1995; 92: 10590-4.
45. Xiao ZC, Bartsch U, Margolis RK, Rougon G, Montag D, Schachner M. Isolation of a tenascin-R binding protein from mouse brain membranes. A phosphacan-related chondroitin sulfate proteoglycan. J Biol Chem1997; 272: 32092-101.
46. Falk J, Bonnon C, Girault JA, Faivre-Sarrailh C. F3/contactin, a neuronal cell adhesion molecule implicated in axogenesis and myelination. Biol Cell 2002; 94: 327-34.
47. Kazarinova-Noyes K, Malhotra JD, McEwen DP, Mattei LN, Berglund EO, Ranscht B, et al. Contactin associates with Na+ channels and increases their functional expression. J Neurosci 2002; 21: 7517-25.
48. Kottis V, Thibault P, Mikol D, Xiao ZC, Zhang R, Dergham P, et al. Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J Neurochem. 2002; 82: 1566-9.
49. Yiu G, He Z. Signaling mechanisms of the myelin inhibitors of axon regeneration. Curr Opin Neurobiol 2003; 13: 545-51.
50. Apostolski S, Sadiq SA, Hays A, Corbo M, Suturkova-Milosevic L, Chaliff P, et al. Identification of Gal(beta 1-3)GalNAc bearing glycoproteins at the nodes of Ranvier in peripheral nerve. J Neurosci Res 1994; 38: 134-41.
51. Huang JK, Phillips GR, Roth AD, Pedraza L, Shan W, Belkaid W, et al. Glial membranes at the node of Ranvier prevent neurite outgrowth. Science 2005; 310: 1813-7.
52. Nie DY, Ma QH, Law JWS, Chia CP, Dhingra NK, Shimoda Y, et al. Oligodendrocytes regulate formation of nodes of Ranvier via the recognition molecule OMgp. Neuron Glial Biology 2006; in press (doi: 10.1017/S1740925X06000251).
53. Dawe GS, Schachne, M, Patterson M, Xiao ZC. Ensheathing the Node of Ranvier? Neuron Glial Biology 2006; in press (doi: 10.1017/ S1740925X06000159).
54. Isom LL. The role of sodium channels in cell adhesion. Front Biosci 2002; 7: 12-23.
55. Chen C, Westenbroek RE, Xu X, Edwards CA, Sorenson DR, Chen Y, et al. Mice lacking sodium channel betal subunits display defects in neuronal excitability, sodium channel expression, and nodal architecture. J Neurosci 2004; 24: 4030-42.
56. McEwen DP, Meadows LS, Chen C, Thyagarajan V, Isom LL. Sodium channel betal subunit-mediated modulation of Nav 1.2 currents and cell surface density is dependent on interactions with contactin and ankyrin. J Biol Chem 2004; 279: 16044-9.
57. Weber P, Bartsch U, Rasband MN, Czaniera R, Lang Y, Bluethmann H, et al. Mice deficient for tenascin-R display alterations of the extracellular matrix and decreased axonal conduction velocities in the CNS. J Neurosci 1999; 19: 4245-4262.
58. Fuss B, Wintergerst ES, Bartsch U, Schachner M. Molecular haracterization and in situ mRNA localization of the neural recognition molecule J1-160/180: A modular structure similar to tenascin. J Cell Biol 1993; 120:1237-1249.
59. Probstmeier R, Nellen J, Gloor S, Wernig A, Pesheva P. Tenascin-R is expressed by Schwann cells in the peripheral nervous system. J Neurosci Res 2001; 64: 70-78.
60. Xiao ZC, Revest JM, Laeng P, Rougon G, Schachner M, Montag D. Defasciculation of neurites is mediated by tenascin-R and its neuronal receptor F3/11. J Neurosci Res 1998; 52: 390-404.
61. Srinivasan J, Schachner M, Catterall WA. Interaction of voltage-gated sodium channels with the extracellular matrix molecules tenascin-C and tenascin-R. Proc Natl Acad Sci USA 1998; 95: 15753-15757.
62. Xiao ZC, Ragsdale DS, Malhotra JD, Mattei LN, Braun PE, Schachner M, et al. Tenascin-R is a functional modulator of sodium channel beta subunits. J Biol Chem 1999; 274: 26511-26517.
63. Evers MR, Salmen B, Bukalo O, Rollenhagen A, Bosl MR, Morellini F, et al. Impairment of L-type Ca2+ channel-dependent forms of hippocampal synaptic plasticity in mice deficient in the extracellular matrix glycoprotein tenascin-C. J Neurosci 2002; 22: 7177-7194.
64. Martin S, Levine AK, Chen ZJ, Ughrin Y, Levine JM. Deposition of the NG2 proteoglycan at nodes of Ranvier in the peripheral nervous system. J Neurosci 2001; 21: 8119-8128.
65. Jones LL, Yamaguchi Y, Stallcup WB, Tuszynski MH. NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J Neurosci 2002; 22: 2792-2803.
66. Stallcup WB, Dahlin K, Healy P. Interaction of the NG2 chondroitin sulfate proteoglycan with type VI collagen. J Cell Biol 1990; 111: 3177-3188.
67. Stegmuller J, Werner H, Nave KA, Trotter J. The proteoglycan NG2 is complexed with alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by the PDZ glutamate receptor interaction protein (GRIP) in glial progenitor cells. Implications for glial-neuronal signaling. J Biol Chem 2003; 278: 3590-3598.
68. Barritt DS, Pearn MT, Zisch AH, Lee SS, Javier RT, Pasquale EB, et al. The multi-PDZ domain protein MUPP1 is a cytoplasmic ligand for the membrane-spanning proteoglycan NG2. J Cell Biochem 2000; 79: 213-224.
69. Oohashi T, Hirakawa S, Bekku Y, Rauch U, Zimmermann DR, Su WD, et al. Brall, a brain-specific link protein, colocalizing with the versican V2 isoform at the nodes of Ranvier in developing and adult mouse central nervous systems. Mol Cell Neurosci 2002; 19: 43-57.
70. Wu Y, Chen L, Zheng PS, Yang BB. Beta 1-Integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M/versican. J Biol Chem 2002; 277: 12294-12301.
71. Perissinotto D, Iacopetti P, Bellina I, Doliana R, Colombatti A, Pettway Z, et al. Avian neural crest cell migration is diversely regulated by the two major hyaluronan-binding proteoglycans PG-M/versican and aggrecan. Development 2000; 127: 2823-2842.
72. Peles E, Nativ M, Campbell PL, Sakurai T, Martinez R, Lev S, et al. Thecarbonic anhydrase domain of receptor tyrosine phosphatase beta is a functionalligand for the axonal cell recognition molecule contactin. Cell 1995; 82: 251-260.
73. Ratcliffe CF, Qu Y, McCormick KA, Tibbs VC, Dixon JE, Scheuer T, et al. A sodium channel signaling complex: Modulation by associated receptorprotein tyrosine phosphatase beta. Nat Neurosci 2000; 3: 437-444.
74. Sakurai T, Lustig M, Nativ M, Hemperly JJ, Schlessinger J, Peles E, et al. Induction of neurite outgrowth through contactin and Nr-CAM by extracellular regions of glial receptor tyrosine phosphatase beta. J Cell Biol 1997; 136: 907-918.
75. Habib AA, Martou LS, Allwardt B, Gulcher JR, Mikol DD, Hognason T, et al. Expression of the oligodendrocyte-myelin glycoprotein y neurons in the mouse central nervous system. J Neurochem 1998; 70:1704-1711.
76. Habib AA, Gulcher JR, Hognason T, Zheng L, Stefansson K. The OMgp gene, a second growth suppressor within the NF1 gene. Oncogene 1998; 16: 1525-1531.
77. Hu WH, Hausmann ON, Yan MS, Walters WM, Wong PK, Bethea JR. Identification and characterization of a novel Nogo-interacting mitochondrial protein (NIMP). J Neurochem 2002; 81: 36-45.
78. Taketomi M, Kinoshita N, Kimura K, Kitada M, Noda T, Asou H, et al. Nogo-A expression in mature oligodendrocytes of rat spinal cord in association with specific molecules. Neurosci Lett 2002 332: 37-40
79. Vinson M, Strijbos PJ, Rowles A, Facci L, Moore SE, Simmons DL, et al. Myelin-associated glycoprotein interacts with ganglioside GT1b. A mechanism for neurite outgrowth inhibition. J Biol Chem 2001; 276: 20280-20285.
80. Domeniconi M, Cao Z, Spencer T, Sivasankaran R, Wang K, Nikulina E, et al. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron 2002; 35: 283-290.
81. Yang H, Xiao ZC, Becker B, Hillenbrand R, Rougon G, Schachner M. Role for myelin-associated glycoprotein as a functional tenascin-R receptor. J Neurosci Res 1999; 55: 687-701.
82. Franzen R, Tanner SL, Dashiell SM, Rottkamp CA, Hammer JA, Quarles RH. Microtubule-associated protein 1B: A neuronal binding partner for myelin-associated glycoprotein J Cell Biol 2001; 155: 893-898.
83. Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 2002; 3: 705-714.
84. Johnson G, Moore SW. The peripheral anionic site of acetylcholinesterase: Structure, functions and potential role in rational drug design. Curr Pharm Des 2006; 12(2): 217-25.
85. Kastin AJ, Pan W. Targeting neurite growth inhibitors to induce CNS regeneration. Curr Pharm Des 2005; 11(10): 1247-53.
86. Tsai EC, Tator CH. Neuroprotection and regeneration strategies for spinal cord repair. Curr Pharm Des 2005; 11(10): 1211-22.